Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HTR7 | P34969 | 2/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12014341 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD | |
| SCHEMBL1404044 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD | |
| SCHEMBL12014345 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD | |
| SCHEMBL12014335 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD | |
| SCHEMBL12014339 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD | |
| SCHEMBL1403881 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD | |
| SCHEMBL12014338 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD | |
| SCHEMBL1403807 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD | |
| SCHEMBL12014344 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD | |
| SCHEMBL1404065 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2KEAP1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1399409-B1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF SE (DE) | 2012-10-31 | — | — | EP | claimed |
| CN-100349851-C | Method for producing acrylic acid esters | BASF AG (DE) | 2007-11-21 | — | — | CN | claimed |
| CN-100349854-C | Method for producing (meth) acrylic acid esters | BASF AG (DE) | 2007-11-21 | — | — | CN | claimed |
| US-7026503-B2 | Method for producing (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-11 | — | — | US | claimed |
| EP-1399408-B1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AG (DE) | 2006-03-22 | — | — | EP | claimed |
| US-10174349-B2 | Recombinant cell producing 2-hydroxyisobutyric acid | EVONIK ROEHM GMBH (DE) | 2019-01-08 | — | — | US | disclosed |
| EP-2291530-B1 | RECOMBINANT CELL PRODUCING 2-HYDROXYISOBUTYRIC ACID | EVONIK ROEHM GMBH (DE) | 2018-12-26 | — | — | EP | disclosed |
| US-9176378-B2 | Resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-03 | — | — | US | disclosed |
| US-8728707-B2 | Resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8728707-B2 | Resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-05-20 | — | — | US | disclosed |
| CN-101186603-B | Process for preparing tetramethyl glycolide | EVONIK ROEHM GMBH | 2014-01-08 | — | — | CN | disclosed |
| US-8568956-B2 | Resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-10-29 | — | — | US | disclosed |
| EP-2091906-A1 | PROCESS FOR PREPARING (METH)ACRYLIC ACID | Evonik Röhm GmbH (DE) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008061819-A1 | PROCESS FOR PREPARING (METH)ACRYLIC ACID | EVONIK RÖHM GMBH (DE) | 2008-05-29 | — | — | WO | disclosed |
| WO-2008061821-A1 | PROCESS FOR PREPARING TETRAMETHYL GLYCOLIDE | EVONIK RÖHM GMBH (DE) | 2008-05-29 | — | — | WO | disclosed |
| CN-101186568-A | Process for preparing (meth)acrylic acid | EVONIK ROEHM GMBH (DE) | 2008-05-28 | — | — | CN | disclosed |
| CN-101186603-A | Process for preparing tetramethyl glycolide | EVONIK ROEHM GMBH (DE) | 2008-05-28 | — | — | CN | disclosed |
| US-6727232-B2 | NEW SERIES OF NUCLEOSIDE PEPTIDE ANTIBIOTICS OF AA-896 | WYETH HOLDINGS CORPORATION | 2004-04-27 | — | — | US | disclosed |
| US-20030054983-A1 | Antibiotics AA-896 | AMERICAN CYANAMID COMPANY | 2003-03-20 | — | — | US | disclosed |
| WO-2002085867-A1 | ANTIBIOTICS AA-896 | WYETH HOLDINGS CORPORATION (US) | 2002-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030054983-A1 | Antibiotics AA-896 | Q6ZSR9, O60361, CYP2A6 | KDM4E 3030/4885ALDH1A1 395/4885SMN1; SMN2 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.